ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Memory Pharmaceuticals Corp (MM)

Memory Pharmaceuticals Corp (MM) (MEMY)

0.606
0.00
(0.00%)
Closed November 12 3:00PM
0.606
0.00
( 0.00% )
Pre Market: 6:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.606
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.606
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

MEMY Latest News

Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.

NUTLEY, N.J. and BASEL, Switzerland, Jan. 2 /PRNewswire-FirstCall/ -- Roche (SWX: ROG.VX; RO.S; OTCQX; RHHBY) today announced that its wholly-owned subsidiary 900 North Point Acquisition...

Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia

MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that it has dosed the first patient in its Phase 2 clinical study of the effect of...

BridgewaterEquity.com Free Fundamental Sector & Market Research on COLM, EGLE, FMCN and MEMY

LONDON -- (Marketwire) -- 12/22/08 -- BridgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers...

Memory Pharmaceuticals Reports Phase 1 Data for R4996/MEM 63908

MONTVALE, N.J., Dec. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced positive results from its Phase 1 program for R4996/MEM 63908, a partial agonist of...

Memory Pharmaceuticals Initiates Phase 2a Trial for MEM 1414 in Asthma

Study to Evaluate Proof-of-Concept for Company's Lead PDE4 Inhibitor MONTVALE, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that it has...

Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement

MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that the NASDAQ Listing and Hearing Review Council has determined that the Company...

Memory Pharmaceuticals Receives NASDAQ Decisions

- Company Granted Stay of Delisting by NASDAQ Review Council - MONTVALE, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that, on December 3...

Beacon Equity Issues Technical Trade Alerts on Market Movers: DIOD, MEMY, CSUN, CLWR, BARE, CHRS

DALLAS, Nov. 26 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...

Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

NUTLEY, N.J. and MONTVALE, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Roche and Memory Pharmaceuticals (NASDAQ:MEMY) today announced that the two companies have signed a definitive merger agreement...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MVSTMicrovast Holdings Inc
US$ 0.3391
(87.66%)
1.35M
NMHINatures Miracle Holding Inc
US$ 0.1456
(69.89%)
6.03M
CYCCCyclacel Pharmaceuticals Inc
US$ 0.54
(31.71%)
112.11k
DAVEDave Inc
US$ 82.05
(30.65%)
373
MAPSWM Technology Inc
US$ 0.9231
(28.92%)
459
SYRSSyros Pharmaceuticals Inc
US$ 0.40
(-85.35%)
138.75k
SIDUSidus Space Inc
US$ 1.27
(-43.56%)
60.61k
VRMVroom Inc
US$ 5.20
(-41.38%)
1.18k
NANano Labs Ltd
US$ 6.07
(-21.17%)
4.42k
GRPNGroupon Inc
US$ 8.95
(-20.94%)
4.01k
NMHINatures Miracle Holding Inc
US$ 0.1456
(69.89%)
6.03M
MVSTMicrovast Holdings Inc
US$ 0.3391
(87.66%)
1.35M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 20.39
(3.45%)
819.16k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 4.34
(-3.13%)
397.82k
TSLQInvestment Managers Series Trust II Tradr 2X Short TSLA Daily
US$ 7.92
(-3.30%)
386k

Discussion

View Full Feed
No Posts Found

Your Recent History